Trial intelligence / Profile preview

The REPERATOR Study

NCT00286312Phase 4Completed

Sponsor
R&D Cardiologie
Start
Feb 2006
Primary completion
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in myocardial infarction (MI), reperfusion injury (IRI), sponsored by R&D Cardiologie. Started Feb 2006; status: completed.

02

Drugs

atorvastatin
03

Conditions

myocardial infarction (MI)reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT00286312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00286312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call